Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease

Journal of Applied Physiology

Volumn 112, Issue 1, 2012, Pages 42-47

  Kao, Christina C ^a,b   Hsu, Jean W C ^b   Bandi, Venkata ^a   Hanania, Nicola A ^a   Kheradmand, Farrah ^a   Jahoor, Farook ^b  

^a Critical Care   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cachexia; Glycolysis; Nutrition

Indexed keywords

GLUCOSE; PYRUVIC ACID;

AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GLYCOLYSIS; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

AGED; CASE-CONTROL STUDIES; FEMALE; GLUCOSE; GLYCOLYSIS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRUVIC ACID; SEVERITY OF ILLNESS INDEX;

EID: 84855392628     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00599.2011     Document Type: Article

References (31)

1. Bolton CE, Evans M, Ionescu AA, Edwards SM, Morris RH, Dunseath G, Luzio SD, Owens DR, Shale DJ. Insulin resistance and inflammation: A further systemic complication of COPD. COPD 4: 121-126, 2007. (Pubitemid 47164861)
2. Calvert LD, Shelley R, Singh SJ, Greenhaff PL, Bankart J, Morgan MD, Steiner MC. Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 1090-1094, 2008. (Pubitemid 351717567)
3. Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 52: 396-401, 1998. (Pubitemid 28284776)
4. Eker S, Ayaz L, Tamer L, Ulubas B. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease. Scand J Clin Lab Invest 70: 40-44, 2010.
5. Engelen MP, Deutz NE, Wouters EF, Schols AM. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 1488-1492, 2000.
6. Engelen MP, Schols AM, Does JD, Gosker HR, Deutz NE, Wouters EF. Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 1697-1704, 2000.
7. Franssen FM, Sauerwein HP, Ackermans MT, Rutten EP, Wouters EF, Schols AM. Increased postabsorptive and exercise-induced wholebody glucose production in patients with chronic obstructive pulmonary disease. Metabolism 60: 957-964, 2011.
8. Franssen FM, Sauerwein HP, Rutten EP, Wouters EF, Schols AM. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur Respir J 32: 1466-1471, 2008.
9. Gold PM. The 2007 GOLD Guidelines: A comprehensive care framework. Respir Care 54: 1040-1049, 2009.
10. Green HJ, Bombardier E, Burnett M, Iqbal S, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol 295: R935-R941, 2008.
11. Green HJ, Burnett ME, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease. J Appl Physiol 105: 879-886, 2008.
12. Hjalmarsen A, Aasebo U, Birkeland K, Sager G, Jorde R. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab 22: 37-42, 1996.
13. Jakobsson P, Jorfeldt L. Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia. Clin Physiol Funct Imaging 26: 271-274, 2006. (Pubitemid 44269801)
14. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 151: 374-377, 1995.
15. Jakobsson P, Jorfeldt L, von Schenck H. Insulin resistance is not exhibited by advanced chronic obstructive pulmonary disease patients. Clin Physiol 15: 547-555, 1995.
16. Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor F. Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease. Metabolism 60: 1449- 1455, 2011.
17. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Belanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55: 848-853, 2000.
18. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153: 288-293, 1996. (Pubitemid 26026864)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985. (Pubitemid 15018832)
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 26: 319-338, 2005. (Pubitemid 41079078)
21. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL, Peters A. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169: 1231-1237, 2004. (Pubitemid 38680401)
22. Philipson LH.αAgonists and metabolism. J Allergy Clin Immunol 110: S313-S317, 2002.
23. Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 453-457, 1998. (Pubitemid 28090534)
24. Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia. Nutrition 27: 138-143, 2011.
25. Rutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr 83: 829-834, 2006. (Pubitemid 44713147)
26. Schiffelers SL, Blaak EE, Baarends EM, Van Baak MA, Saris WH, Wouters EF, Schols AM.αAdrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 280: E357-E364, 2001.
27. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 54: 983-987, 1991. (Pubitemid 21917663)
28. Shangraw RE, Jahoor F. Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis. Metabolism 53: 1087-1094, 2004. (Pubitemid 38988299)
29. 2 production from doubly labeled water in humans. Am J Physiol Endocrinol Metab 264: E912-E917, 1993. (Pubitemid 23198566)
30. Wang Z, Deurenberg P, Wang W, Pietrobelli A, Baumgartner RN, Heymsfield SB. Hydration of fat-free body mass: Review and critique of a classic body-composition constant. Am J Clin Nutr 69: 833-841, 1999. (Pubitemid 29205055)
31. Wolfe RR, Jahoor F, Miyoshi H. Evaluation of the isotopic equilibration between lactate and pyruvate. Am J Physiol Endocrinol Metab 254: E532-E535, 1988.